IBC's 2nd Protein Kinases

Last Modified: April 28, 2002

Conference Dates: September 9-10, 2002
Conference Location: Seaport Hotel, Boston, Massachusetts, USA


Sponsoring Group: IBC Life Sciences

Conference Web Page URL: www.LifeSciencesInfo.com/kinases/?source=2722-5

Topics Covered:

  • Defining Kinase Selectivity as a Predictor in Clinical Development
  • New Lead Discovery for Kinase Inhibitors
  • Kinase Target Discovery and Validation
  • Identifying New Kinase Inhibitor Templates
  • Kinases in Oncology and Non-Oncology
  • Indications Developing Technologies to Evaluate Selectivity/Toxicity of Kinase Inhibitors
  • Developing Specific Kinase Inhibitors: Role of Cellular Assay

Registration Information: Available online

Continuing Education: No

Blogs

Don't Assume You Understand
by Bob Riter
July 29, 2015

Related News

Guidelines Aim to Reduce 2nd Surgeries Post-Lumpectomy

Nov 14, 2014

Currently, one in four women require a follow-up surgery


ASCO: Ramucirumab Extends Survival As 2nd-Line NSCLC Tx

Jun 3, 2014

Addition of ramucirumab to standard docetaxel chemo prolongs progression-free, overall survival


ASCO: Continuing Avastin With 2nd-Line Chemo Ups Survival

Jun 6, 2012

Findings in patients with metastatic colorectal cancer treated with first-line chemo plus Avastin